Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $88.06 USD
Change Today -0.13 / -0.15%
Volume 69.0K
ALOG On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gina R. Consylman

Former Principal Accounting Officer, Vice President and Corporate Controller, Analogic Corporation
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

41--

Background*

Ms. Gina R. Consylman has been Chief Accounting Officer, Vice President and Corporate Controller at Ironwood Pharmaceuticals, Inc. since June 2014. Ms. Consylman served as Vice President and Corporate Controller of Analogic Corporation from February 27, 2012 to June 2014 and served as its Principal Accounting Officer from March 15, 2012 to June 13, 2014. Ms. Consylman has held a number of key financial leadership roles in high growth, global healthcare and technology ...

Read Full Background

Corporate Headquarters*

8 Centennial Drive
Peabody, Massachusetts 01960

United States

Phone: 978-326-4000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS
Bentley University
BS
Johnson & Wales University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALOG:US $88.06 USD -0.13

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
$557.2K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
$440.2K
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$650.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANALOGIC CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.